Nursing News

anemia detection by smartphoneNo bleeding required:
Anemia detection via smartphone

  • Developed and tested by student with beta-thalassemia

Atlanta, GA, USA (December 4, 2018) - Biomedical engineers have developed a smartphone app for the non-invasive detection of anemia. Instead of a blood test, the app uses photos of someone's fingernails taken on a smartphone to accurately measure how much hemoglobin is in their blood. The results are scheduled for publication in Nature Communications.

Too few fully trained nurses linked to daily 3 percent rise in patient death risk

  • No let-up in risk when headcount boosted with unregistered nursing assistants

London, UK (December 4, 2018) - But plugging the gap with unregistered nursing assistants isn't associated with any diminution in patient harm, suggesting that while these healthcare workers have a key role in maintaining ward safety, "they cannot act as substitutes for [registered nurses]," say the researchers.

One in four patients say they've skimped on insulin because of high cost

New Haven, CT, USA (December 2018) - For patients with diabetes, insulin is a life-saving medicine and an essential component of diabetes management, yet in the past decade alone, the out-of-pocket costs for insulin have doubled in the United States. One-quarter of patients with type 1 or 2 diabetes have reported using less insulin than prescribed due to these high costs, Yale researchers write in JAMA Internal Medicine, and over a third of those patients experiencing cost-related underuse said they never discussed this reality with their provider.

knickerbockerFear of being judged and embarrassed are among the reasons

Why patients lie to their doctors

Salt Lake City, Utah, USA (November 30, 2018) - When your doctor asks how often you exercise, do you give her an honest answer? How about when she asks what you've been eating lately? If you've ever stretched the truth, you're not alone. 60 to 80 percent of people surveyed have not been forthcoming with their doctors about information that could be relevant to their health, according to a new study. Besides fibbing about diet and exercise, more than a third of respondents didn't speak up when they disagreed with their doctor's recommendation. Another common scenario was failing to admit they didn't understand their clinician's instructions.

sleepFalls are more likely when you've had a bad night sleep

  • Just one night of disturbed sleep means you are less capable to control posture and balance the day after
  • A single bad night sleep decreases your chance of controlling posture according to researchers at the University of Warwick, who have used state of the art sensors to monitor sleep and balance
  • Implications could be that older people who have had a bad night sleep are the most at risk of a fall

  • Innovative solutions of how to prevent imminent falls can now be researched

Coventry, UK (November 30, 2018) - Disturbances during sleep decreases capability to control posture and balance according to researchers from the Department of Engineering and Warwick Medical School at the University of Warwick who have an article published today in Scientific Reports.

Strong painkillers increase the risk of hip fracture among persons with Alzheimer's disease

JOENSUU, KUOPIO, Finland (November 26, 2018) - People using strong painkillers, opioids, have twice the risk of hip fracture compared to non-opioid users, a new study from the University of Eastern Finland shows. The risk was highest in the first two months of opioid use. The results were published in the PAIN journal.

Screening tools can miss sepsis in pregnancy: study urges action

  • New research reveals a need for better tools for catching severe infections in pregnant women; simple early interventions are crucial, too

Lansing, Michigan (November 21, 2018) - A woman lies in her hospital bed. Her heart rate is elevated, she has a slight fever and an elevated white blood cell count. Could this be the beginnings of sepsis, a life-threatening reaction to an infection? Or could these simply be signs of a normal pregnancy?

Concomitant use of sleeping pills and strong painkillers is common among people with AD

Kuopio, Finland (November 19, 2018) - One in five people with Alzheimer's disease (AD) who use a benzodiazepine are also concomitant users of an opioid, according to a new study from the University of Eastern Finland. Concomitant use was more common in comparison persons, but those with AD used strong opioids more frequently. About half of all concomitant users were prolonged users whose use of these drugs had continued for more than three consecutive months.

Having poor vision can raise risk for falls among older adults

New York, NY (November 19, 2018) - Vision impairment and blindness affect one in 11 Americans age 65 and older. Because our population is aging, the number of older adults with vision problems is predicted to rise. Older adults who have impaired vision may be at risk for decreased independence, poorer well-being, and an increased risk of falls. For example, in any given year, approximately 30 percent of adults over age 65 will fall. Having impaired vision more than doubles this risk.

New blood test detects early stage ovarian cancer

Adelaide, Australia (November 19, 2018) - Research on a bacterial toxin first discovered in Adelaide has led to the development a new blood test for the early diagnosis of ovarian cancer - a disease which kills over 1000 Australian women and 150,000 globally each year. The new blood test has the potential to dramatically improve early detection of the disease, although it will require further testing before it is available for clinicians.

Scientists trained a computer to classify breast cancer tumors

Chapel Hill, NC (November 19, 2018) - Using technology similar to the type that powers facial and speech recognition on a smartphone, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have trained a computer to analyze breast cancer images and then classify the tumors with high accuracy.

Noise pollution in hospitals - a rising problem

London, UK (November 18, 2018) - In an editorial published today in the BMJ, researchers from King's College London and the University of the Arts London (UAL) argue that it is a worsening problem, with levels regularly exceeding international recommendations. "Even in intensive care units, which cater for the most vulnerable patients, noise levels over 100dB have been measured, the equivalent of loud music through headphones," said lead author Dr Andreas Xyrichis.

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 November 2018

  • EMA’s human medicines committee (CHMP) recommended four medicines for approval, including a medicine for use in countries outside the European Union, at its November 2018 meeting.

London, UK (November 16, 2018) - The CHMP adopted a positive opinion for Fexinidazole Winthrop (fexinidazole), the first oral-only medicine (tablets) for the treatment of human African trypanosomiasis, commonly known as sleeping sickness, due to Trypanosoma brucei gambiense. This is the tenth medicine recommended by EMA under Article 58, a mechanism that allows the CHMP to assess and give opinions on medicines for use outside the European Union. For more information, please see the press release in the grid below.

Brown researchers develop new test to objectively measure pain, test medications

PROVIDENCE, R.I., USA (November 7, 2018) -- If you've ever visited the emergency department with appendicitis, or you're one of the 100 million U.S. adults who suffer from chronic pain, you're familiar with a row of numbered faces, with expressions from smiling to grimacing, used to indicate pain levels.  Despite that tool's widespread use, some researchers say a more empirical approach would better serve both patients and the physicians who provide care.

33.000 people die every year due to infections with antibiotic-resistant bacteria

Solna, Sweden (November 6, 2018) - An ECDC study estimates the burden of five types of infections caused by antibiotic-resistant bacteria of public health concern in the European Union and in the European Economic Area (EU/EEA). The burden of disease is measured in number of cases, attributable deaths and disability-adjusted life years (DALYs). These estimates are based on data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) from 2015.

Your showerhead slime is alive

Boulder, Col., USA (November 1, 2018) - The day after Halloween, something scary may still lurk inside your showerhead. Researchers at CIRES have identified Mycobacterium as the most abundant genus of bacteria growing in the slimy "biofilm" that lines the inside of residential showerheads--and some of those bacteria can cause lung disease.

Drugs' side effects in lungs 'more widespread than thought'

Manchester, UK (October 29, 2018) - A systematic review of research has revealed that the toxic effects on the lung of drugs commonly taken to treat a range of common conditions is much more widespread than thought. Though the 27 drugs treating a range of conditions including arthritis, cancer and the heart are successful for most patients, doctors, say the team, need to be more aware of the potential risks to their respiratory systems.

Study of 500,000 people clarifies the risks of obesity

Bristol, UK (October 25, 2018) - Elevated body mass index (BMI) - a measure of weight accounting for a person's height - has been shown to be a likely causal contributor to population patterns in mortality, according to a new study led by the University of Bristol using measurements and mortality data from 500,000 people. Specifically, for those in UK Biobank (a study of middle to late aged volunteers), every 5kg/m2 increase in BMI was associated with an increase of 16 per cent in the chance of death and 61 per cent for those related to cardiovascular diseases. The work is published today [Thursday 25 October] in Obesity Editors' Choice.

Houston Methodist scientists create device to deliver immunotherapy without side effects

  • Single direct-to-tumor drug-delivery device offers hope for treating triple-negative breast cancer

HOUSTON-(Oct. 23, 2018) - Houston Methodist scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. Inserted straight into a tumor, this nanofluidic seed makes it possible to deliver a one-time, sustained-release dose that would eliminate the need for patients to undergo several IV treatments over time.

Nurse-led care significantly more successful in treating gout, trial reveals

Nottingham, UK (October 18, 2018) - The research, led by academics at the University of Nottingham and published in The Lancet, has shown that keeping patients fully informed and involving them in decisions about their care can be more successful in managing gout. And the study, which was funded by the charity Versus Arthritis, highlights the importance of individualised patient education and engagement to treat the condition.

2014 regulations led to modest staffing increases but no reduction in rates of patient mortality or complications

Mass. ICU nurse staffing regulations did not improve patient mortality and complications

BOSTON, MA, USA (September 4, 2018) -In 2014, Massachusetts lawmakers passed a law requiring a 1:1 or 2:1 patient-to-nurse staffing ratio in intensive care units (ICU) in the state, as guided by a tool that accounts for patient acuity and anticipated care intensity. The regulations were intended to ensure patient safety in the state's ICUs, but new research led by physician-researchers at Beth Israel Deaconess Medical Center (BIDMC) and published today in Critical Care Medicine found the staffing regulations were not associated with improved patient outcomes.

Surgical outcomes equivalent whether physician anesthesiologist assisted by nurse anesthetist or AA

CHICAGO, ILL, USA (May 29, 2018) - Patients who undergo inpatient surgery experience no difference in death rates, hospital length of stay or costs between admission or discharge whether their physician anesthesiologist is assisted by a nurse anesthetist or an anesthesiologist assistant, according to a new study published in the Online First edition of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists (ASA).

New model defines successful nurse practitioner-physician co-management

A theoretical model to alleviate primary care strain

Leawood, KS, USA (May 14, 2018) - Co-management of patients by more than one primary care clinician is among new models of care designed to meet the demand for high quality patient care. A new co-management model lays the groundwork for potential care partnerships between nurse practitioners and physicians.

Effort seeks to increase the number of trained rheumatology nurse practitioners and physician assistants

Due to an aging population and increasing prevalence of rheumatic disease, there are growing demands on clinicians who specialize in rheumatology. To meet these demands, the American College of Rheumatology has developed a formal curriculum for nurse practitioners (NPs) and physician assistants (PAs). The curriculum is described in Arthritis Care & Research.

The development of a formal NP/PA curriculum outline in rheumatology is novel and can serve as a tool when adding NPs/PAs into clinical rheumatology practice. No other medical specialty has yet created an endorsed, standardized training tool that can aid in the preparation of NPs/PAs in a medical specialty.

"The Rheumatology Curriculum Outline is a practical tool that can be utilized in various adult and pediatric practice settings," said lead author Benjamin J. Smith, of Florida State University College of Medicine School of Physician Assistant Practice. "We anticipate that it will be used broadly to positively affect rheumatology workforce challenges."

Wiley, April 19, 2018 (tB).

Overcome key challenges in daily diabetes therapy

Integration of latest technology and Personalised Diabetes Management promotes improved outcomes and more time in range

  • Only 6.5% of people with diabetes in Europe reach their therapy targets1
  • Clinical inertia is a key contributor to this and needs to be overcome2 – in a joint effort of physicians, people with diabetes, healthcare systems and industry
  • Latest study evidence shows that integrating innovative technologies and the structured therapy approach of Personalised Diabetes Management improves therapy outcomes and contributes to a better overall glycemic control3
  • An open ecosystem approach with integrated diabetes management solutions addresses clinical inertia and promotes the achievement of more time in range.

Vienna, Austria (February 14, 2018) - Despite all technological innovations of the past years, still only 6.5% of people living with diabetes in Europe are able to achieve their individual therapy targets. Research shows that this can mainly be attributed to multiple factors described as clinical inertia, which includes patient, physician and system-related factors such as e.g. disease denial, medication issues, depression, poor health literacy, too little time in the doctor’s office or poor communication.4 Experts reckon clinical inertia to contribute to people with diabetes living with suboptimal glycemic control for many years, with dramatic consequences in terms of quality of life, morbidity and mortality. This also has a huge impact on the healthcare system due to the high costs associated with uncontrolled diabetes.5

Obesity seen as self-inflicted

Berlin, Germany (February 2, 2018) - Representative survey in Germany, the UK, and the US: Although experts attribute the worldwide increase in obese people primarily to environmental changes, the general public lays the blame on individuals. In their opinion, those suffering from obesity should pay for any resulting medical expenses themselves. This is shown in a current study by the Max Planck Institute for Human Development and the University of Mannheim, published in Annals of Behavioral Medicine.

Patient Blood Management Program

Blueprint to reduce wasteful blood transfusions

Baltimore, Maryland, USA (November 20, 2017) -- By analyzing data from randomized clinical trials comparing blood transfusion approaches, Johns Hopkins experts, along with colleagues at Cleveland Clinic and NYU Langone Medical Center, endorse recommendations for blood transfusions that reduce blood use to improve patient safety and outcomes. Publishing this week in JAMA Internal Medicine, the report also provides a how-to guide for launching a patient blood management program.

Late-Breaking Data Presented at IHC Highlight Primary and Secondary Outcome Measure Results from Chronic and Episodic Migraine Phase III Clinical Trials

Teva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine

Jerusalem, Israel (September 9, 2017) – Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) has presented new data evaluating fremanezumab, an investigational treatment for the prevention of migraine, at the 18th Congress of the International Headache Society (IHC) in Vancouver, Canada. Data presented across two platform presentations and five late-breaking abstracts featured detailed positive efficacy results from pivotal Phase III HALO studies of fremanezumab in chronic (CM) and episodic migraine (EM), as well as data from patient-reported outcomes tools in the chronic migraine trial.

More than 35 presentations and sessions showcase Shire’s gene therapy pipeline and leading factor portfolio: Shire to present new data at ISTH 2017 to advance the standard of care in haemophilia

Zug, Switzerland (June 23, 2017) – Shire plc (LSE: SHP, NASDAQ: SHPG), a leading biotechnology company focused on serving individuals with rare diseases, will present research covering a broad range of rare bleeding disorders at the 26th Biennial International Society on Thrombosis and Haemostasis Congress (ISTH), July 8-13, 2017 in Berlin, Germany. Showcased in eight oral presentations, 29 poster presentations and three symposia, these data underscore Shire’s pursuit of treatment innovation rooted in safety, efficacy, and individualized care for hemophilia patients.


Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2016

  • Seven medicines recommended for authorisation, 81 overall in 2016

London, GB (December 16, 2016) - The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended seven new medicines for marketing authorisation at its December 2016 meeting. This brings the total number of medicines recommended for approval by the CHMP in 2016 to 811.

Nine medicines recommended for approval, including three biosimilars

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 November 2016

London, GB (November 11, 2016) - The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended nine medicines for approval at its November meeting. The CHMP recommended granting a marketing authorisation for Afstyla (lonoctocog alfa) for the prevention and treatment of bleeding in patients with haemophilia A.

Toward a hand-held 'breathalyzer' for diagnosing diabetes

Washington, DC, USA (November 9, 2016) - For several years, scientists have been working toward "breathalyzers" that can diagnose various diseases without painful pinpricks, needles or other unpleasant methods. Now, one team has developed a new, portable breath analyzer that could someday help doctors diagnose diabetes noninvasively in the office. The report appears in the ACS journal Analytical Chemistry.

WHO recommends 29 ways to stop surgical infections and avoid superbugs

Geneva, Switzerland November 3, 2016) - People preparing for surgery should always have a bath or shower but not be shaved, and antibiotics should only be used to prevent infections before and during surgery, not afterwards, according to new guidelines from WHO that aim to save lives, cut costs and arrest the spread of superbugs.

New Guideline on Management of Older Patients with CKD

(November 2, 2016) - In the industrialized world, the average age of dialysis patients is constantly rising. People have now a significantly higher life expectancy than 50 years ago, and chronic kidney disease (CKD) is a disease that often occurs in older age. The CKD and dialysis populations are aging, thus posing new challenges for nephrology. Older patients have more comorbidities, a different physiology and, of course, a shorter life expectancy. The latter aspect, especially, may impact therapeutic decisions, for example whether renal replacement therapy should be initiated or conservative treatment be maintained.

Hospital readmission history a valid measure of skilled nursing quality

PROVIDENCE, R.I., USA (November 1, 2016) --When an elderly loved one is discharged from a hospital to a skilled nursing facility (SNF), the family's hope is that they will get good care that will allow them to return home rather than poor care that requires a return trip to the hospital. That's why on its Nursing Home Compare website, the federal government recently included an SNF's historical track record of 30-day hospital readmissions in its ratings of care quality.

Pic.: The aim of OPTIMISTIC -- an acronym for Optimizing Patient Transfers, Impacting Medical quality and Improving Symptoms: Transforming Institutional Care -- is to improve care and communication within nursing facilities and between these facilities and acute-care institutions. Credit: Indiana University Center for Aging Research OPTIMISTIC study

Advance care planning in nursing homes challenging but critical

INDIANAPOLIS , Indiana, USA (November 1, 2016) - The goal of advance care planning is to ensure that the health care an individual receives is consistent with his or her values and preferences. New research shows the critical need for advance care planning and highlights the challenges that healthcare institutions -- especially nursing homes -- face in supporting high quality advance care planning.

Pembrolizumab (KEYTRUDA) Checkpoint Inhibitor for the treatment of patients with metastatic non-small cell lung cancer (NSCLC)

Silver Springs, MD, USA (October 25, 2016) - On October 24, 2016, the U.S. Food and Drug Administration approved pembrolizumab (KEYTRUDA, Merck & Co., Inc.) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors express PD-L1 as determined by an FDA-approved test.


Thousands of melanoma patients in Europe have no access to new life saving drugs

COPENHAGEN, Denmark (October 7, 2016 ) - Over 5000 patients with metastatic melanoma in Europe are denied access to new, life saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen1. Metastatic melanoma is an aggressive and deadly skin cancer. With innovative targeted therapy and immunotherapy, patients can survive for many years. Unfortunately new therapies are expensive so, according to a survey conducted by Dr Lidija Kandolf-Sekulovic, over 5000 patients with metastatic melanoma in Europe have no access to these drugs.

Researchers look at the role of bacteria in incontinence

Weethinking the role of bacteria in incontinence

Lausanne, Switzerland (October 7, 2016) - We all know that feeling of suddenly needing to pee, and the agonizing worry that we might not find a toilet in time or make it that far. Sadly, for many people this is a regular occurrence and wetting themselves uncontrollably is an inevitable consequence. Almost 1 in 5 women over the age of 44 suffer from what is known as Urgency Urinary Incontinence (UUI): experiencing a strong sensation of an urgent need to pee, followed by immediate leakage of a large volume of urine. It can severely adversely affect someone's life, contributing to anxiety, depression and social isolation.

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2016

  • Eleven medicines recommended for approval, including three medicines for cancer

London, UK (September 16, 2016) - The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended eleven medicines for approval at its September meeting. The CHMP recommended granting a conditional marketing authorisation for Lartruvo (olaratumab) for the treatment of adults with advanced soft tissue sarcoma. Lartruvo is to be used in combination with doxorubicin (a chemotherapy medicine) in patients with advanced soft tissue sarcoma for whom surgery or radiotherapy is not suitable, and who have not been previously treated with doxorubicin. Lartruvo was reviewed under EMA’s accelerated assessment mechanism and has an orphan designation. For more information, please see the press release in the grid below.

Accu_Chek Insight CGM app. Photo and Copyright: RocheUnique features and innovative design

Roche Diabetes Care’s new Accu-Chek® Guide wireless blood glucose monitoring system offers smart solutions for easier testing

                                    • Accuracy surpasses the ISO 15197:2013/EN ISO 15197:201510 requirements for blood glucose monitoring systems
                                    • Easy-to-use with an intuitive user interface and improved testing experience
                                    • Connectivity to the Accu-Chek Connect diabetes management system enables online data exchange with healthcare professionals and caregivers

Munich, Germany (September 12, 2016) - On August 31, 2016, Roche Diabetes Care received clearance by the U.S. Food and Drug Administration (FDA) for the new Accu-Chek Guide blood glucose monitoring system that has been designed to address previously unmet needs of patients and their healthcare professionals. The Accu-Chek Guide system offers a combination of unique features and an innovative design which make it easy and safe to use.